| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 06/01/2006 | US20060117416 Isolated polynucleotide which encodes a transmembrane protein with similarities to plasma membrane Na+/H+ antiporters from bacteria and fungi confering salt tolerance |
| 06/01/2006 | US20060117409 Modified ribulose 1,5-bisphosphate carboxylase/oxygenase for improvement and optimization of plant phenotypes |
| 06/01/2006 | US20060117408 Expression cassettes for guard cell-preferential expression in plants |
| 06/01/2006 | US20060116343 Sphingosine kinase-1 mediates gene expression regulation of a monocyte chemoattractant protein-1 gene |
| 06/01/2006 | US20060116338 Therapeutic and diagnostic tools for proliferative and developmental disorders and as vehicles for identifying region q26.2 on a mammalian chromosome 3; gene therapy; detecting Cornelia de Lange syndrome; diagnosing neoplasia; inducing a cell to change its pattern of differentiation |
| 06/01/2006 | US20060115897 Compositions and methods modulating variola and vaccinia virus |
| 06/01/2006 | US20060115896 Diagnostic test for west nile virus |
| 06/01/2006 | US20060115875 Characterizing hepatitis C viral infection by determining a similarity between a viral sequence of an hypervariable region 1 (HVR1) of the second envelope protein (E2) region of an hepatitis C virus that infected the host and a variable region kappa light chain of an immunoglobulin of the host |
| 06/01/2006 | US20060115874 Enrichment method for variant proteins with altered binding properties |
| 06/01/2006 | US20060115872 Culture medium and a method for detection of parasites |
| 06/01/2006 | US20060115871 Protein interaction reporter agents and methods for using same |
| 06/01/2006 | US20060115870 High throughput assay for human Rho kinase activity |
| 06/01/2006 | US20060115869 Uses of carbamoyl phosphate synthetas for the diagnosis of inflammatory diseases and sepsis |
| 06/01/2006 | US20060115868 Activation mixture |
| 06/01/2006 | US20060115864 Identifying modulators of ubiquitin-mediated proteolysis; treatment and prevention of cell proliferative, arthritic and respiratory system disorders |
| 06/01/2006 | US20060115863 Inositol phosphate detection assays |
| 06/01/2006 | US20060115859 Tyrosylprotein sulfotransferases and methods of use thereof |
| 06/01/2006 | US20060115858 Trace amine 1 receptor of the African green monkey |
| 06/01/2006 | US20060115857 for sensing the presence of an analyte component without relying on redox mediators; conductive polymer/double-stranded DNA strands aligned in uniaxial orientation with plurality of molecular recognition headgroups having an affinity for the analyte component and being attached to the ends of the strands |
| 06/01/2006 | US20060115853 Polynucleotides, polypeptides and method for screening for useful dog candidates |
| 06/01/2006 | US20060115852 proteins or polypeptides comprising amino acid sequences, used for diagnosis and therapy of diseases associated with oncogenes, such as transcription and apoptosis |
| 06/01/2006 | US20060115851 Artificial genes for use as controls in gene expression analysis systems |
| 06/01/2006 | US20060115850 Method for the synthesis of DNA fragments |
| 06/01/2006 | US20060115849 Screening methods |
| 06/01/2006 | US20060115848 Nucleic acid end-labeling reagents |
| 06/01/2006 | US20060115847 immunological TB diagnostic tool based on a combination of epitopes from proteins encoded by regions of the M. tuberculosis genome that are not present in the BCG vaccine strain or in the most common non-tuberculosis mycobacteria |
| 06/01/2006 | US20060115846 Antigenic binding patterns of norovirus to human histo-blood group antigens |
| 06/01/2006 | US20060115845 Using chromosome 3q13.31 marker profiling as diagnostic tool in detection of cardiovascular disorders |
| 06/01/2006 | US20060115844 Enhanced amplifiability of minute fixative-treated tissue samples, minute stained cytology samples, and other minute sources of DNA |
| 06/01/2006 | US20060115843 Diagnostic test for Collie Eye Anomaly |
| 06/01/2006 | US20060115842 Highly sensitive homogeneous assay based on anti-Stokes' shift FRET measurement |
| 06/01/2006 | US20060115841 Method and system for elucidating the primary structure of biopolymers |
| 06/01/2006 | US20060115840 In situ dilution of external controls for use in microarrays |
| 06/01/2006 | US20060115839 Methods of identifying an agent that modulates an interaction between 53BP1 and histone H3, and uses thereof |
| 06/01/2006 | US20060115838 Real-time detection of amplicons using nucleic acid repair enzymes |
| 06/01/2006 | US20060115837 Crystals and structure of domain III of West Nile Virus envelope protein in association with a Fab fragment of a neutralizing antibody |
| 06/01/2006 | US20060115836 Utilization of FANCC, DAD1, GRIM19 and HADHII genes for the ultimate treatment of psoriasis |
| 06/01/2006 | US20060115835 Method for the carry-over protection in DNA amplification systems targeting methylation analysis achieved by a modified pre-treatment of nucleic acids |
| 06/01/2006 | US20060115833 Method and apparatus for determining base sequence of nucleic acid molecule |
| 06/01/2006 | US20060115832 Detection of cancer cells in body fluids |
| 06/01/2006 | US20060115831 Map |
| 06/01/2006 | US20060115830 Methods for monitoring genomic DNA of organisms |
| 06/01/2006 | US20060115829 An isolated nucleic acid sequence encoding a DNA methyltransferase-3B variant having aseleted amino acid sequence; screening for enzyme inhibitor compounds to be used as anticarcinogenic agents for, particularly, lung cancer and, more particularly, non-small cell lung cancer |
| 06/01/2006 | US20060115828 Detection device having increased detection rate, and method for quick detection of biological molecules |
| 06/01/2006 | US20060115827 Genetic markers for predicting disease and treatment outcome |
| 06/01/2006 | US20060115826 Gene expression profiling for identification monitoring and treatment of multiple sclerosis |
| 06/01/2006 | US20060115825 PNA chip using zip-codes and fabrication method thereof |
| 06/01/2006 | US20060115824 Trend analysis and statistical process control using multitargeted screening assays |
| 06/01/2006 | US20060115823 For detecting entero-hemorrhagic Escherichia coli in clinical examinations, public health examinations, food evaluations and food poisoning examinations; oligonucleotides preferable for composing a rapid and specific gene testing reagent |
| 06/01/2006 | US20060115822 Systems and methods for probe design |
| 06/01/2006 | US20060115821 Prostate specific genes and the use thereof as targets for prostate cancer therapy |
| 06/01/2006 | US20060115820 Primer and probe for detecting vibrio cholerae or vibrio mimicus and detection method using the same |
| 06/01/2006 | US20060115819 Detection, identification and differentiation of eubacterial taxa using a hybridization assay |
| 06/01/2006 | US20060115818 Diagnostic and therapeutic means for kidney stone related pathologies |
| 06/01/2006 | US20060115817 Span-xb gene and protein for the diagnosis and treatment of cancer |
| 06/01/2006 | US20060115816 Splice variant cannabinoid receptor (cb1b) |
| 06/01/2006 | US20060115815 Method and compositions for identifying anti-hiv therapeutic compounds |
| 06/01/2006 | US20060115814 Methods and compositions, relating to hiv gp41 antigens and other hiv envelope antigens |
| 06/01/2006 | US20060115813 Intracellular signaling molecules |
| 06/01/2006 | US20060115812 Detecting hyperplasia or adenocarcinoma of the endometrium; measuring and comparing levels of stress-induced phosphoprotein-1 |
| 06/01/2006 | US20060115811 Cytochrome p450ra1-2 and related proteins |
| 06/01/2006 | US20060115810 Microarrays of functional biomolecules, and uses therefor |
| 06/01/2006 | US20060115809 Microarrays of functional biomolecules, and uses therefor |
| 06/01/2006 | US20060115808 Microarrays of functional biomolecules, and uses therefor |
| 06/01/2006 | US20060115807 Episomal expression system |
| 06/01/2006 | US20060115806 Global analysis of transposable elements as molecular markers of cancer |
| 06/01/2006 | US20060115805 Gelatine-based materials as swabs |
| 06/01/2006 | US20060115804 Method of studying living cells |
| 06/01/2006 | US20060115490 vaccines, immunogenic compositions; diagnostics, enzymatic studies and targets for antibiotics; for treating Staphylococcus aureus infection |
| 06/01/2006 | US20060115479 Nucleic acids coding for adhesion factor of group b streptococcus, adhesion factors of group b streptococcus and further uses thereof |
| 06/01/2006 | DE19910102B4 Proteinkonjugate, Verfahren, Vektoren, Proteine und DNA zu deren Herstellung, deren Verwendung, sowie Arzneimittel und Impfstoffe mit einem Gehalt derselben Protein conjugates, methods, vectors, proteins, and DNA for their preparation, their use, as well as drugs and vaccines containing the same |
| 06/01/2006 | DE19653685B4 In vitro Zellsystem vaskulärer glatter Muskulatur für pharmakologische und physiologische Untersuchungen In vitro cell system vascular smooth muscle for pharmacological and physiological studies |
| 06/01/2006 | DE10260931B4 Verfahren zur Bestimmung der Homeostase behaarter Haut Method for determining the homeostasis hairy skin |
| 06/01/2006 | DE102004056980A1 Verfahren zur ortsspezifischen Synthese von Biopolymeren auf festen Trägern A method for site-specific synthesis of biopolymers on solid supports |
| 06/01/2006 | DE102004054928A1 Test strip, useful for detecting analytes in liquids, comprises carrier layer with reagent(s) impregnated absorbing test layer, which with one thin material present on the side next to the test layer couples with the carrier layer |
| 06/01/2006 | DE10150959B4 Verfahren zur quantitativen Bestimmung viraler Partikel mit cholesterinhaltiger Hülle A method for quantitative determination of viral particles with cholesterol-shell |
| 06/01/2006 | DE10016881B4 Gezielte Transfektion von Zellen mittels biotinyliertem Dendrimer Targeted transfection of cells using biotinylated dendrimer |
| 06/01/2006 | CA2630475A1 Mer diagnostic and therapeutic agents |
| 06/01/2006 | CA2590331A1 Harnessing network biology to improve drug discovery |
| 06/01/2006 | CA2589754A1 Yeast strain and screening method for identifying inhibitors of the expression of the hexose transporter genes by a positive phenotype |
| 06/01/2006 | CA2589561A1 Treatment of neurodegenerative diseases by the use of laptm4a |
| 06/01/2006 | CA2589487A1 Means and methods for detecting methylated dna |
| 06/01/2006 | CA2589459A1 Method of measuring cholesterol in remnant-like lipoproteins |
| 06/01/2006 | CA2589456A1 Trichloro silyl alkyl isocyanate molecule and surface modified mineral substrate |
| 06/01/2006 | CA2589318A1 Inhibitors of biotin protein ligase |
| 06/01/2006 | CA2589315A1 Kits and methods for detecting methylated dna |
| 06/01/2006 | CA2589291A1 Method of detecting kidney dysfunction |
| 06/01/2006 | CA2589279A1 Methods to identify, prepare, and use naive t cell recent thymic emigrants |
| 06/01/2006 | CA2589151A1 Method for directing nucleic acids to plastids |
| 06/01/2006 | CA2588997A1 Sensing phage-triggered ion cascade (septic) |
| 06/01/2006 | CA2588865A1 Detection of nucleic acid variation by cleavage-amplification method |
| 06/01/2006 | CA2588705A1 Diagnosis of prostate cancer |
| 06/01/2006 | CA2588420A1 Device and method for detection of analytes |
| 06/01/2006 | CA2588326A1 Method of measuring the number of mircoorganisms and apparatus for measuring the number of microorganisms |
| 06/01/2006 | CA2587643A1 Method for designing polypeptides for the nanofabrication of thin films, coatings, and microcapsules by electrostatic layer-by-layer self assembly |
| 06/01/2006 | CA2586093A1 Methods for cultivating lawsonia intracellularis |
| 06/01/2006 | CA2586092A1 Human obesity susceptibility gene encoding a member of the neurexin family and uses thereof |
| 05/31/2006 | EP1662008A2 Apparatus for and method of purifying nucleic acids by using beads with different laser absorption |
| 05/31/2006 | EP1662007A1 Preventive or remedy for inflammatory bowel diseases containing anti-cd81 antibody as the active ingredient |
| 05/31/2006 | EP1662006A1 Partially double stranded nucleic acid molecule |